🇺🇸 FDA
Pipeline program

UC-MSCs

RenminHJiangYingan

Phase 2 mab active

Quick answer

UC-MSCs for Cirrhosis Due to Hepatitis B is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Cirrhosis Due to Hepatitis B
Phase
Phase 2
Modality
mab
Status
active

Clinical trials